uniQure N.V. (QURE) Balance Sheet

The sharp increase in total assets in 2026Q2 to $985.1M, driven by a $413.0M cash balance, suggests a significant capital infusion, likely from a financing event. However, the prior quarter's equity of $149.3M and the negative equity in 2025Q2 and 2024Q4 indicate that the company has repeatedly relied on external funding to sustain operations. This pattern implies a balance sheet that is not yet stable, with the trajectory dependent on the success of AMT-130 and the ability to secure non-dilutive capital.

The sudden increase in total debt to $536.6M in 2025Q4, followed by a drop to $62.8M in 2026Q2, suggests a temporary drawdown or conversion of debt, possibly related to the royalty sale or a bridge financing. The elevated D/E in 2025Q4 and the historical peaks in 2024 (8.98 and 5.50) indicate that the company has used debt as a stopgap when equity was constrained. This pattern suggests that leverage is necessity-driven rather than strategic, and investors should monitor the terms of any outstanding debt, as the company's negative operating margins may limit its ability to service it.

The increase in cash to $413.0M in 2026Q2, up from $80.2M in 2025Q4, suggests a major capital raise, possibly through equity or debt, which has temporarily bolstered liquidity. However, the decline in net PPE from $72.2M to $23.0M over the period indicates minimal investment in fixed assets, consistent with the prior cash flow analysis showing negligible capex. This suggests that the company is not expanding its manufacturing footprint, potentially relying on existing capacity or outsourcing, which may limit long-term scalability. Goodwill and intangibles are small, reducing impairment risk, but the asset base is increasingly dominated by cash, which may not generate returns.

The persistent negative retained earnings, now at -$1.5B, indicate that the company has never generated sustainable profits, and the equity base is heavily reliant on external capital infusions. The negative equity in 2025Q2 and 2024Q4 highlights the fragility of the balance sheet, where liabilities exceeded assets. The lack of share repurchases and the reliance on stock-based compensation (as noted in prior analysis) suggest that dilution is a continuous drag on existing shareholders. The recent equity increase to $324.1M in 2026Q2 is likely due to a capital raise, but the quality of equity remains low, as it is not backed by retained earnings but by investor contributions.

The current ratio of 10.01 in 2026Q2 is exceptionally strong, indicating that current assets far exceed current liabilities, providing a buffer against near-term obligations. However, the cash balance of $413.0M, while substantial, must be viewed against the quarterly burn rate of over $50M, suggesting a runway of roughly eight quarters. The volatility in cash, from $80.2M in 2025Q4 to $413.0M in 2026Q2, underscores the reliance on discrete financing events. Investors should monitor whether the company can achieve regulatory milestones for AMT-130 to reduce burn or secure additional funding before the cash is depleted.